Please assess the completion status of the following clinical trial:

Trial Title: Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria~* Patients must have a suspicious lung nodule for clinical stage I NSCLC.~* Pathologic confirmation at the time of surgery is acceptable. Patients randomized to SBRT require core biopsy for diagnosis prior to treatment.~* Patient must have a mass ≤ 5 cm maximum diameter by CT size estimate that is clinical stage I (T1N0, T2N0)~* Patient must have a CT scan of the chest and upper abdomen and PET-scan within 60 days prior to date of registration.~* Patient must have an Eastern Cooperative Oncology Group (ECOG) or Zubrod performance status 0, 1, or 2.~* Patient must meet at least one major criteria or meet a minimum of two minor criteria as described below:~Major Criteria:~* Forced expiratory volume in one second (FEV1) ≤ 50% predicted~* Carbon monoxide diffusing capacity (DLCO) ≤ 50% predicted~Minor Criteria:~* Age ≥75~* FEV1 51-60% predicted~* DLCO 51-60% predicted~* Pulmonary hypertension (defined as a pulmonary artery systolic pressure greater than 40 mmHg) as estimated by echocardiography or right heart catheterization~* Poor left ventricular function (defined as an ejection fraction of 40% or less)~* Resting or Exercise Arterial oxygen partial pressure (pO2) ≤ 55 mm Hg or blood oxygen saturation (SpO2) ≤ 88%~* pCO2 \> 45 mm Hg~* Modified Medical Research Council (MMRC) Dyspnea Scale ≥ 3.~Exclusion Criteria~* Patient must not have had previous intra-thoracic radiation therapy.~* No prior malignancy except adequately treated non-melanoma skin cancer, in situ cervical cancer, localized prostate cancer, stage 0 Chronic lymphocytic leukemia (CLL), or other cancer disease-free \> 3 yrs.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Randomized Sublobar Resection (Type: ACTIVE_COMPARATOR): Randomized by computer to receive a sublobar resection.
- Randomized SBRT (Type: ACTIVE_COMPARATOR): Randomized by computer to receive Stereotactic Body Radiotherapy (SBRT).
- Observation Sublobar Resection (Type: ACTIVE_COMPARATOR): Patient decides with doctor to undergo a sublobar resection.
- Observation SBRT (Type: ACTIVE_COMPARATOR): Patient decides with doctor to undergo SBRT.

Based on this trial design, predict the completion outcome and termination type (if applicable).